Market data not licensed for redistribution.
GeneOne Life Science
011000 ยท KOSPI ยท Pharmaceuticals Manufacturing
Close
Source: Financial Services Commission stock price data (data.go.kr), updated once a day.
Daily price, 1 year
Key statistics
Market cap (KRW bn)โ
PERโ
PBRโ
ROE %-137.1
Debt ratio % (liabilities / equity)249
Revenue TTM (KRW bn)12.4
Op. profit TTM (KRW bn)-39.9
Dividend yield %โ
Basis: market cap at โฆ; equity = total equity (consolidated if available) at 2026.06.30; net income = trailing 12 months to 2026.06.30 (consolidated). PER is not shown when TTM net income is negative.
Upcoming risk events
Next 90 days for this company, plus macro events tagged with this ticker or its sector. Not a recommendation.
| 2026-11-04 | Convertible bonds (CB): conversion / exercise period starts โ 2.67% of shares ยท price โฉ2,192 ยท refix floor โฉ1,534 (70.0%) ยท size โฉ5.0bn | Low |
Other scheduled dates (routine, not risks) (1)
- 2026-10-30 ยท Routine schedule: shareholder meeting
Annual results (KRW bn)
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | 38.7 | 48.7 | 40.2 | 35.7 | 23.0 |
| Operating profit | -27.5 | -40.1 | -48.4 | -43.0 | -44.0 |
| Net income | -16.0 | -38.2 | -77.8 | -48.5 | -51.9 |
Quarterly results (KRW bn, 3 months)
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | |
|---|---|---|---|---|---|---|
| Revenue | 8.5 | 6.8 | 5.1 | 2.7 | 2.6 | 2.1 |
| Operating profit | -9.1 | -10.2 | -11.7 | -13.1 | -2.3 | -12.8 |
| Net income | -8.8 | -15.4 | -11.5 | -16.1 | -2.4 | -18.9 |
Largest shareholder
Not yet loaded (pulled in batches across days to respect the DART API quota).
Recent disclosures
| Date | Filing | Summary | |
|---|---|---|---|
| 2026-10-29 | Delisting / administrative issue designation ๊ธฐํ์์ฅ์๋ด (์์ฅ์ ๊ฒฉ์ฑ ์ค์ง์ฌ์ฌ ๊ฒฐ๊ณผ ์๋ด) | DART original | |
| 2026-10-29 | CB conversion / price adjustment [๊ธฐ์ฌ์ ์ ]์ฃผ์์ฌํญ๋ณด๊ณ ์(์๊ธฐ์ ํ์ฌ์ฑ๋งค๋๊ฒฐ์ ) | DART original | |
| 2026-10-23 | Other material event (investment-relevant) ๊ธฐํ๊ฒฝ์์ฌํญ(์ข ์ํ์ฌ์์ฃผ์๊ฒฝ์์ฌํญ) | GeneOne Life Science: Other material event (investment-relevant) | DART original |
| 2026-10-23 | Rights offering (paid-in capital increase) [๊ธฐ์ฌ์ ์ ]์ฃผ์์ฌํญ๋ณด๊ณ ์(์ ์์ฆ์๊ฒฐ์ ) | DART original | |
| 2026-10-21 | Litigation ์์ก๋ฑ์ํ๊ฒฐใ๊ฒฐ์ (์ผ์ ๊ธ์ก์ด์์์ฒญ๊ตฌ) | DART original | |
| 2026-10-15 | Rights offering (paid-in capital increase) [๊ธฐ์ฌ์ ์ ]์ฃผ์์ฌํญ๋ณด๊ณ ์(์ ์์ฆ์๊ฒฐ์ ) | DART original | |
| 2026-10-14 | Shareholder meeting [๊ธฐ์ฌ์ ์ ]์ฃผ์ฃผ๋ช ๋ถํ์๊ธฐ๊ฐ๋๋๊ธฐ์ค์ผ์ค์ | DART original | |
| 2026-10-14 | Shareholder meeting [๊ธฐ์ฌ์ ์ ]์ฃผ์ฃผ์ดํ์์ง๊ฒฐ์ | DART original | |
| 2026-10-12 | Other material event (investment-relevant) [๊ธฐ์ฌ์ ์ ]๊ธฐํ๊ฒฝ์์ฌํญ(์ข ์ํ์ฌ์์ฃผ์๊ฒฝ์์ฌํญ) | DART original | |
| 2026-10-08 | Other material event (investment-relevant) [๊ธฐ์ฌ์ ์ ]๊ธฐํ๊ฒฝ์์ฌํญ(์ข ์ํ์ฌ์์ฃผ์๊ฒฝ์์ฌํญ) | DART original | |
| 2026-10-07 | Other ์ฃผ์์ฌํญ๋ณด๊ณ ์(์๊ธฐ์ ํ์ฌ์ฑ๋ง๊ธฐ์ ์ทจ๋๊ฒฐ์ ) | DART original | |
| 2026-09-30 | Rights offering (paid-in capital increase) [๊ธฐ์ฌ์ ์ ]์ฃผ์์ฌํญ๋ณด๊ณ ์(์ ์์ฆ์๊ฒฐ์ ) | DART original |
Past material filings and price reaction (market-adjusted)
| Date | Filing type | On the news (vs. market) | Next day (vs. market) | 20 days (vs. market) |
|---|---|---|---|---|
| 2026-06-18 | Clarification of rumor / inquiry | -7.0% | -17.5% | -11.9% |
| 2026-06-17 | Clarification of rumor / inquiry | -0.5% | -6.5% | -21.5% |
| 2026-04-14 | Acquisition of shares in another company | -0.6% | -7.6% | -0.9% |
| 2026-04-14 | Rights offering (paid-in capital increase) | -0.6% | -7.6% | -0.9% |
| 2026-04-09 | Delisting / administrative issue designation | -5.8% | +6.3% | +32.7% |
| 2026-04-07 | Delisting / administrative issue designation | -4.6% | -14.7% | +7.7% |
| 2026-03-23 | Other material event (investment-relevant) | -2.3% | -6.7% | +27.0% |
| 2026-03-20 | Capital reduction | -9.6% | +8.0% | +2.0% |
| 2026-03-20 | Trading halt | -9.6% | +8.0% | +2.0% |
| 2026-03-19 | Unfaithful-disclosure notice | -2.9% | +4.0% | -28.9% |
For information only, not investment advice. Data may be delayed or inaccurate. Full disclaimer โ Data: OpenDART (FSS), stock prices: official previous-day close from the Financial Services Commission (data.go.kr) and FinanceData/marcap history, index data via FinanceDataReader, FX: ECB reference rates, crypto data from Upbit, Bithumb and Binance public APIs.
Market data not licensed for redistribution.
ยฉ Crypvu ยท Crypto market view
Market data not licensed for redistribution.
ยฉ Crypvu ยท Crypto market view